Cooper Financial Group Buys 796 Shares of Humana Inc. (NYSE:HUM)

Cooper Financial Group boosted its stake in Humana Inc. (NYSE:HUM) by 95.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,630 shares of the insurance provider’s stock after purchasing an additional 796 shares during the period. Cooper Financial Group’s holdings in Humana were worth $729,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Cibc World Market Inc. increased its position in shares of Humana by 4.0% during the 1st quarter. Cibc World Market Inc. now owns 5,709 shares of the insurance provider’s stock valued at $2,484,000 after purchasing an additional 217 shares during the last quarter. Blair William & Co. IL boosted its stake in shares of Humana by 0.6% during the 1st quarter. Blair William & Co. IL now owns 5,660 shares of the insurance provider’s stock worth $2,463,000 after acquiring an additional 32 shares during the last quarter. Cetera Investment Advisers grew its position in shares of Humana by 0.5% during the 1st quarter. Cetera Investment Advisers now owns 4,906 shares of the insurance provider’s stock valued at $2,135,000 after acquiring an additional 26 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of Humana by 19.0% in the 1st quarter. Sequoia Financial Advisors LLC now owns 615 shares of the insurance provider’s stock worth $268,000 after purchasing an additional 98 shares in the last quarter. Finally, Candriam Luxembourg S.C.A. grew its holdings in Humana by 25.0% during the first quarter. Candriam Luxembourg S.C.A. now owns 29,809 shares of the insurance provider’s stock valued at $12,971,000 after purchasing an additional 5,964 shares during the period. 91.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently issued reports on HUM shares. Argus downgraded Humana from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Morgan Stanley cut their price target on Humana from $637.00 to $624.00 and set an “overweight” rating for the company in a research note on Wednesday, August 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $597.00 price objective on shares of Humana in a research note on Thursday. Barclays cut their price objective on shares of Humana from $620.00 to $585.00 in a report on Monday, June 19th. Finally, Mizuho reduced their price target on shares of Humana from $615.00 to $550.00 in a report on Tuesday, July 11th. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $592.30.

Humana Stock Performance

HUM stock opened at $470.63 on Friday. Humana Inc. has a twelve month low of $423.29 and a twelve month high of $571.30. The firm has a market cap of $58.32 billion, a price-to-earnings ratio of 17.56, a PEG ratio of 1.22 and a beta of 0.66. The business’s fifty day simple moving average is $467.45 and its two-hundred day simple moving average is $487.11. The company has a quick ratio of 1.37, a current ratio of 1.37 and a debt-to-equity ratio of 0.58.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $8.94 earnings per share for the quarter, beating analysts’ consensus estimates of $8.88 by $0.06. The company had revenue of $26.75 billion during the quarter, compared to analyst estimates of $25.83 billion. Humana had a net margin of 3.42% and a return on equity of 20.70%. The firm’s revenue for the quarter was up 13.0% on a year-over-year basis. During the same quarter last year, the business posted $8.67 EPS. Analysts predict that Humana Inc. will post 28.25 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is presently 13.21%.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.